| mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
| mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.8 |
| mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.0095 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |